M. K. Lawrence

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

P. Gosse, S. Oparil, Pankaj Gupta, 2022, The Lancet.

ANTIVIRAL ACTIVITY IN MILK OF POSSIBLE CLINICAL IMPORTANCE

D. Tyrrell, M. K. Lawrence, T. Matthews, 1976, The Lancet.

Serum interferon assay as a possible test for virus infections of man

M. K. Lawrence, T. Matthews, 2005, Archives of Virology.

Identifying and treating resistant hypertension in PRECISION: A randomized long‐term clinical trial with aprocitentan

Ji-Guang Wang, K. Narkiewicz, I. Kantola, 2022, Journal of clinical hypertension.